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Background: Titanium dioxide nanoparticles have numerous applications, resulting in human 
exposure. Nonetheless, available toxicological and safety data are insufficient regarding 
aspherical particles, such as rod-shaped nanoparticles.
Methods: In a combined in vitro–in vivo approach, cultured A549 lung alveolar adenocar-
cinoma cells were treated with approximately 15×65 nm TiO
2
 nanorod-containing medium, 
while young adult rats received the same substance by intratracheal instillation for 28 days in 
5 and 18 mg/kg body-weight doses. Nanoparticle accumulation in the lungs and consequent 
oxidative stress, cell damage, and inflammation were assessed by biochemical and histopatho-
logical methods.
Results: Titanium was detected in tissue samples by single-particle inductively coupled plasma 
mass spectrometry. Nanoparticles were visualized inside cultured A549 cells, within pulmonary 
macrophages, and in hilar lymph nodes of the rats. A549 cells showed dose-dependent oxidative 
stress and lethality, and the observed nanoparticle-laden endosomes suggested deranged lyso-
somal function and possible autophagy. Strongly elevated Ti levels were measured in the lungs 
of nanorod-treated rats and moderately elevated levels in the blood of the animals. Numerous 
cytokines, indicating acute and also chronic inflammation, were identified in the lung samples 
of TiO
2
-exposed rodents.
Conclusion: Several signs of cell and tissue damage were detected in both the cultured alveolar 
cells and in treated rats’ lungs. Rod-shaped nanoparticulate TiO
2
 may consequently be more 
harmful than has generally been supposed. The occupational health risk suggested by the results 
calls for improved safety measures.
Keywords: nanoparticles, toxicity, oxidative stress, autophagy, cytokines, inflammation
Introduction
Titanium dioxide nanoparticles (TiO
2
 NPs) have numerous industrial applications and 
appear in various consumer goods, including food, cosmetics, and medicines. This 
widespread application raises the question of possible human exposure of occupa-
tional, environmental, and/or intentional origin with the potential for negative health 
consequences.
Whenever NPs (particles with at least one dimension 100 nm) are generated, 
purposefully or as by-products, they are likely to be released into the surrounding 
atmosphere, where the formation of an extremely stable aerosol is probable.1 Conse-
quently, inhalation is a major way of human exposure to NPs present in the immediate 
(workplace, residential, or other) environment. NPs inhaled with polluted air are either 
deposited in the nasopharynx or may reach the alveoli in both humans and in rats.2,3 
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Deposition takes place there mainly by diffusion, with high-
est efficiency for particles or agglomerates of 10–100 nm 
diameter.4
The relationship between elevated levels of ambient 
airborne NPs and human morbidity and mortality has been 
generally accepted.1 NPs have large specific surface area, 
which is also very reactive, leading to the generation of 
reactive oxygen species (ROS) in the aqueous microenvi-
ronment of living tissues.5 The resulting oxidative stress can 
overwhelm cellular antioxidant defense mechanisms and 
induce inflammation via activation of the MAPK and NFκB 
pathways, ending up in the release of cytokines.5 NPs can 
affect the mitochondria directly and interfere with oxidative 
phosphorylation, resulting in the generation of even more 
ROS, thereby aggravating oxidative stress and initiating 
apoptosis.6 From a mechanistic perspective, ROS generation 
and oxidative stress make up the best-developed paradigm to 
explain the toxic effects of inhaled NPs. Since there appears 
to be a direct relationship between the surface area of NPs, 
their ROS-generating capacity, and proinflammatory effects 
induced by particles in the lung,7 biochemical consequences, 
such as lipid peroxidation or changes in antioxidant-enzyme 
activities, and in the expression of cytokines, are potential 
biomarkers of NP toxicity (suitable even for toxicity screen-
ing of airborne particles).8
Inflammasomes are protein assemblies with a central 
role in cellular immunoreactions.9 ROS induced by NPs 
directly or via mitochondrial dysfunction, or via effectors 
like cathepsin B emitted from damaged lysosomes, activate 
inflammasomes, which in turn activate the interleukin activa-
tor caspase 1.10 Lysosomal damage itself may result from the 
presence of NPs due to oxidative membrane damage or the 
disrupted processing of phagosomes laden with indigestible 
NPs. Lysosomal leakage and disturbed autophagy may also 
contribute to NP-provoked inflammation and tissue damage.9 
Dysfunction of the cytoskeleton, intracellular transport, and/
or lysosomes may lead to abnormal degradation processes 
and to the release of numerous lysosomal enzymes in the 
cytoplasm.11 On the other hand, autophagy is mutually related 
to the expression and secretion of certain cytokines, including 
IL1, IL18, TNFα, and IFN1.12
The worldwide production of several million tons of TiO
2
 
(including both microscopic and submicroscopic particles) 
suggests first of all an occupational risk. The National Insti-
tute for Occupational Safety and Health has published a limit 
of 0.3 mg/m3 for ultrafine (100 nm diameter) TiO
2
 in the 
workplace atmosphere.13 Actual measurements have proved 
temporary exceedance of this limit during production and 
packaging of nano-TiO
2
,14 whereas model calculations have 
shown a clear positive health risk.15 This is in accordance 
with previous findings proving that workplace exposure to 
airborne TiO
2
 results in decreased ventilatory capacity and 
pleural thickening.16
In rat lungs, Yoshiura et al17 evoked transient inflamma-
tion with activation of cytokines and antioxidant enzymes 
by a single intratracheal application of TiO
2
 NPs (spheres 
of ~25 nm in diameter). In true inhalation exposure in rats, 
it has been found that the intensity of lung-inflammatory 
reaction, cytotoxicity, and oxidative stress after a single 
exposure were dependent on the diameter of the primary 
NPs and their agglomerates.3
Six-hour inhalation of nanosize and pigment-grade TiO
2
 
on 5 consecutive days has induced neutrophilic inflammation 
in the lungs, together with size-dependently variable deposi-
tion of the particles and translocation to local lymph nodes.18 
The importance of deposition and clearance (dependent on 
the NPs’ characteristics) in causing lung inflammation in rats 
was also stressed by Oyabu et al.19 In vitro exposure to TiO
2
 
NPs of the human lung-related alveolar adenocarcinoma-
derived A549 cell line20 has resulted in moderate cytotoxicity 
and altered cytokine release within 24–48 hours.21,22
Most experimental results, including the cited ones point-
ing to the importance of particle size in toxicity, have been 
obtained with spherical NPs. It has been realized, however, 
that in certain practical applications, eg, dye-sensitized solar 
cells,23 therapeutic applications,24 biocompatible implants,25 
or antimicrobial treatment of fabrics,26 other forms (eg, 
nanorods, nanotubes) are preferable, which adds another 
aspect (over size and agglomeration) to features potentially 
influencing the toxicity of NPs, as was concluded recently 
by Wang and Fan.27 A recent report on the shape-dependent 
accumulation of NPs in various organs has revealed that 
rod- or tube-shaped nanomaterials had a clear advantage 
in capacity to concentrate in the respiratory system, and 
thus in lung tissue over their spherical counterparts,28 whereas 
in another study particle size, but not shape, was found to 
influence pulmonary inflammation.29 Related to the increased 
accumulation potential of nanorods in the lungs, the degree of 
exerted toxic effects and nature of induced molecular mecha-
nisms might also differ from those of spherical particles.
Experimental data on general and organ-specific toxicity 
of TiO
2
 NPs are numerous,30,31 but do not settle all questions 
of human health risks resulting from exposure to TiO
2
 NPs. 
The apparent shortage of knowledge and the fact that the 
respiratory system is the first to be confronted with airborne 
NPs shaped our aims. Thus, in the present work, the potential 
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harmful effects of TiO
2
 nanorods on the respiratory tract were 
investigated. It was examined whether NPs and their effects 
could be detected in the alveolar part of the airways, which 
is crucial for respiratory function, and whether the damage 
induced is acute or chronic in character. To elucidate the 
pathomechanism, we used a combined in vitro and in vivo 
experimental approach, where nanorod-exposed rat lungs 
and lung-derived cell cultures were subjected to histological, 
chemical, and biochemical analyses.
Methods
Production and characterization of TiO2 
nanorods
All chemicals for the synthesis of NPs were obtained 
from Sigma-Aldrich (St Louis, MO, USA). Nanorods of 
TiO
2
 ~15×65 nm in size were synthesized from titanate nano-
tubes as intermediate products in a simple alkali hydrothermal 
method as per Madarász et al.32 NaOH solution (1 L, 10 M) 
and 50 g TiO
2
 nanopowder (Degussa P25) were mixed in a 
stainless-steel Teflon-lined autoclave for 24 hours at 428 K 
using continuous rotation at 3 rpm. The as-prepared TiO
2
 
nanostructures were washed thoroughly with deionized water 
to neutral pH, subsequently with 0.1 M HCl several times, 
and finally with water again to obtain a neutral salt-free 
product. Finally, the TiO
2
 nanotubes obtained were heated 
at 600°C for 1 hour in normal air, whereupon TiO
2
 nanorods 
evolved. The size, shape, and crystal structure of the product 
were checked by X-ray diffraction (in a dry state, using the 
database PDF-4),33 dynamic light scattering, and transmission 
electron microscopy (TEM) after suspending the nanomate-
rial in the treatment medium (PBS containing 1% polyacrylic 
acid [PAA] as stabilizing agent at pH 7). Stability of the 
material was tested by comparing these parameters in a fresh 
state and after 4 months of storage at 5°C.
In vitro investigation
a549 cell culture
The A549 lung alveolar adenocarcinoma cell line was pur-
chased from the American Type Culture Collection (Manassas, 
VA, USA). Cells were maintained in low-glucose (1 g/L) 
DMEM (Sigma-Aldrich) complemented with 10% FBS 
(Sigma-Aldrich), 2 mM l-glutamine, 0.01% streptomycin, and 
0.005% ampicillin and cultured under standard conditions in 
a 37°C incubator containing 5% CO
2
 in 95% humidity.
cell-viability test
To estimate the effect of TiO
2
 NPs and PAA alone on the 
viability of A549 cells, 104 cells/well were seeded into 96-well 
plates and exposed to either TiO
2
 NPs or PAA for 24, 48, and 
72 hours. The suspension of TiO
2
 NPs was added to the culture 
medium to achieve concentrations of 0.025–2 mg/mL, while 
for cells in separate wells corresponding amounts of PAA were 
added. After the treatments, the NP- or PAA-containing culture 
medium was removed and cells incubated with 0.5 mg/mL 
yellow MTT reagent (Serva, Heidelberg, Germany) diluted 
in culture medium for 1 hour at 37°C. The formazan crystals 
generated were solubilized in dimethyl sulfoxide (Molar 
Chemicals, Halásztelek, Hungary) and absorbance at 570 nm 
determined using a Synergy HTX plate reader (BioTek, 
Winooski, VT, USA). MTT measurements were repeated three 
times using at least four independent biological replicates.
Detection of reactive oxygen species
To detect the formation of ROS upon nano-TiO
2
 and PAA 
exposure, 2′,7′-dichlorofluorescin diacetate (DCFDA; Sigma-
Aldrich) staining was performed. Cells were cultured for 1 day 
and then treated with TiO
2
 nanorods or PAA for 48 hours. 
Again, TiO
2
 NPs were applied in concentrations ranging of 
0.025–2 mg/mL in the medium, while for cells in separate 
wells the corresponding amount of PAA was added. After 
the treatments, cells were washed with PBS, incubated with 
10 µM DCFDA solution for 1 hour, and fluorescence intensity 
measured with the Synergy HTX plate reader according to the 
manufacturer’s specifications. The experiment was repeated 
three times using at least four independent replicates.
apoptosis detection by annexin V–propidium iodide 
staining
The induction of apoptosis by nano-TiO
2
 exposure of A549 
cells was investigated with annexin V–propidium iodide 
staining. For this purpose, 3×105 A549 cells were seeded into 
six-well plates and left to grow for 24 hours. On the following 
day, cells were exposed to 0.1 mg/mL TiO
2
 NPs or PAA at 
a corresponding concentration. After 24, 48, and 72 hours 
of treatment, cells were stained with Alexa488-conjugated 
annexin V–propidium iodide according to the manufacturer’s 
guidelines (Thermo Fisher Scientific, Waltham, MA, USA). 
Fluorescence intensity was determined by means of flow 
cytometry (FACSCalibur; BD, Franklin Lakes, NJ, USA) 
measuring 10,000 cells and FACS data analyzed with FlowJo 
version 10 software. Experiments were repeated three times 
using at least two biological replicates.
scanning electron microscopy
For scanning electron microscopy (SEM) analysis, 3×105 
A549 cells were seeded onto plastic coverslips (Sarstedt, 
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Nümbrecht, Germany), placed in six-well plates, left to 
grow for 1 day, and then exposed to 0.1 mg/mL TiO
2
 NPs 
for 24 hours. Following that, cells were washed and fixed 
using 2.5% glutaraldehyde (dissolved in modified Sörensen 
buffer, pH 7.6). Samples were dehydrated by solutions 
containing increasing percentages of ethanol in water (50%, 
70%, 80%, 90%, 95%, 98%, and 100%, 15 minutes each), 
followed by a series of tert-butanol:ethanol mixtures (1:2, 
1:1, and 2:1 volume ratio) at room temperature. Then, 
cells were incubated with tert-butanol overnight, at 4°C 
and finally lyophilized. The coverslips were mounted on 
specimen stubs using electrically conductive double-sided 
adhesive tape, and the sample preparation was completed 
with the application of a 4–5 nm metal gold–palladium 
coating, needed to decrease charging artifacts and radia-
tion damage of the biological sample. Field-emission SEM 
imaging was performed with a Hitachi S-4700 using 10 kV 
accelerating voltage and 10 µA emission current. Energy-
dispersive X-ray spectroscopy (EDS) measurements were 
carried out with a Röntec QX2 EDS detector installed on 
the S-4700 using 20 kV accelerating voltage and 10 µA 
emission current.
Transmission electron microscopy
To detect intracellular accumulation of TiO
2
 NPs in A549 
cells, 105 cells were seeded onto 0.4 µm-pore polyester-
membrane inserts (Corning, Corning, NY, USA) placed in 
a six-well plate. On the following day, cells were exposed 
to 0.1 mg/mL TiO
2
 NPs for 24 hours. Treated cells were 
washed in PBS, fixed in 4% glutaraldehyde diluted in PBS 
for 2 hours, and subsequently embedded in gelatin (2% gela-
tin in PBS). The specimen obtained was sliced to 1–2 mm 
cubes, which were further embedded in epoxy (Epon 812; 
Sigma-Aldrich) by a routine TEM sample-preparation proto-
col. Semithin sections of 1 µm were prepared to identify the 
cell monolayer. Blocks were trimmed and thin sections of 
70 nm obtained and stained with uranyl and lead solutions. 
Images were captured with a JEOL 1,400 plus 120 kV using 
100 kV voltage. 
In vivo investigation
animals and treatment
Young adult male specific-pathogen-free Wistar rats 
(Crl:WIBr, 6 weeks old, 170±20 g body weight [BW]) 
were used, 40 in all, obtained from Toxi-Coop (Budapest, 
Hungary). The rats, two per cage, were kept in an animal 
house providing good laboratory practice-equivalent 
conditions (12/12-hour light/dark cycle with light on at 6 am; 
temperature 22°C±3°C, 30%–70% relative humidity), with 
free access to unlimited water and standard rodent food 
(Ssniff R/M-Z + H; also from Toxi-Coop). After 1 week 
of acclimation, animals were randomized to four treatment 
groups of ten rats each, based on spontaneous exploratory 
activity. Groups and corresponding treatments are shown 
in Table 1.
Treatment of the rats was performed 5 days/week for 
28 days, always between 8 and 10 am. The suspension of 
TiO
2
 NPs was applied by intratracheal instillation (1 mL/kg 
BW volume) with brief anesthesia.34 Rat BW was measured 
every morning before treatment to determine the exact 
daily dose to be instilled and to see the effect of treatment 
on BW gain. During the entirety of the in vivo study, the 
principles of the Ethical Committee for the Protection of 
Animals in Research of the University of Szeged were 
strictly followed. The methods used in this work were 
licensed by the Csongrád County Government Office, 
Directorate for Food Chain Safety and Veterinary Health 
(the authority competent in animal-welfare issues) under 
XXI/151/2013.
general toxicological investigation
From the daily BW data, weight gain for each week and 
the whole treatment period was assessed. One day after the 
treatment period, the rats were killed by overdosed urethane 
(double the anesthetic dose,35 given intraperitoneally). 
The thorax was opened, a blood sample of 3–4 mL taken 
from the left ventricle, the rats perfused transcardially with 
300 mL saline at 4°C temperature to remove blood from 
the organs, and then dissected. The rats’ lungs (primary 
target in exposure via the airways) and other organs, such 
as the spleen, liver, kidneys, and the brain (including both 
hemispheres and the cerebellum), were weighed and rela-
tive organ weights (related to 1/100 BW and brain weight) 
calculated. After organs had been weighed, lung samples 
were halved. The right half was shock-frozen in liquid 
nitrogen and stored at -20°C for subsequent measurement 
of biochemical parameters and Ti-level determination, and 
Table 1 groups and treatments
Control Vehicle-
treated
Low  
dose
High  
dose
0.9%  
Nacl
1% Paa  
in PBs
TiO2 NPs
5 mg/kg BW
TiO2 NPs
18 mg/kg BW
Abbreviations: BW, body weight; Paa, polyacrylic acid; NPs, nanoparticles.
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the left half was fixed in 4% neutral buffered formalin for 
histopathological examination.
Titanium-level measurements
The amount of Ti in the lung, blood, and kidney samples 
of TiO
2
 NP-treated and control rats was determined by 
single-particle inductively coupled plasma mass spectrom-
etry (quadrupole 7700x; Agilent, Santa Clara, CA, USA). 
For that, samples were dried to constant weight at 80°C 
and digested using 3 mL HCl/g wet tissue at 90°C, then an 
equal volume of HNO
3
 was added and digested for another 
90 minutes. This procedure has proved necessary to dissolve 
all TiO
2
 reliably.36 The resulting liquid was filtered on a 
0.45 nm hydrophilic membrane filter and diluted to 100 mL 
final volume.
assessment of oxidative tissue damage: lipid 
peroxidation and catalase activity
Lung tissue from all groups (control [C], vehicle-treated 
[VT], low dose [LD], and high dose [HD]) were freeze-
clamped rapidly and powdered with a pestle and mortar in 
liquid nitrogen. For detection of lipid peroxidation by thio-
barbituric acid-reactive substance (TBARS) assay and for 
catalase-activity measurement, 100 µg lung-tissue powder 
was measured from each sample and homogenized in 1 mL 
PBS by three cycles of freeze-thawing in liquid nitrogen. 
Lysates were centrifuged at 8,000 g for 10 minutes and the 
supernatant used for the experiments. Protein concentra-
tions of the lysates were determined with Bradford reagent 
(Bio-Rad, Hercules, CA, USA).
For lipid-peroxidation assessment, the produced 
malondialdehyde (MDA; a secondary product of lipid 
peroxidation) was measured: 50 µL lysates were incubated 
with 450 µL Lp reagent (15% trichloroacetic acid, 0.4% 
thiobarbituric acid, 0.25 M HCl) for 20 minutes at 100°C. 
After centrifugation at 2,000 g for 5 minutes, the absor-
bance of the supernatant was measured at 532 nm.37 For 
assessing catalase activity, 5 µL tissue lysate was mixed 
with PBS (50 mM KH
2
PO
4
, 50 mM Na
2
HPO
4
) containing 
0.1% H
2
O
2
, and absorbance was measured continuously at 
240 nm for 3 minutes. By using the difference in absorption/
min values, catalase activity was expressed in Bergmeyer 
units (BU): 1 BU defines enzyme activity at 25°C, when 
1 g H
2
O
2
 is enzymatically degraded in 1 minute.38 Results 
of TBARS (MDA concentration) assays and of catalase 
activity were normalized to the protein concentration of 
each sample.
cytokine detection
The cytokine profile of lung tissue was determined in a 
semiquantitative way from tissue homogenates using a 
proteome-profiler rat-cytokine array kit (panel A, 29 rat 
cytokines and chemokines; R&D Systems, Minneapolis, 
MN, USA). Factors to be detected by the kit were CINC1, 
CINC2α/β, CINC3, CNTF, fractalkine, GM-CSF, sICAM1, 
IFNγ, IL1α, IL1β, IL1RA, IL2, IL3, IL4, IL6, IL10, IL13, 
IL17, IP10, LIX, l-selectin, MIG, MIP1α, MIP3α, CCL5, 
TIMP1, TNFα, and VEGF.
Powdered lung tissue (20 mg) was taken from each rat, 
and these were lumped together group by group to give 
collective samples of 200 mg. They were homogenized in 
a PBS containing protease-inhibitor cocktail (Roche, Basel, 
Switzerland) and 1% Triton X-100. The samples were frozen 
and thawed three times in liquid nitrogen, and cellular debris 
was removed by centrifugation at 10,000 g for 5 minutes. 
The protein concentration of the supernatants was measured 
with the Bradford reagent. Supernatant quantity correspond-
ing to 400 µg protein was used from each sample for the 
array. Cytokines in the samples were determined by an 
ELISA-based procedure, performed according to the array 
protocol and the instructions provided by the manufacturer. 
Membranes were developed using Chemi reagent mix 
(Immobilon; Merck, Darmstadt, Germany) and chemilumi-
nescent signals detected with a C-Digit blot scanner (Li-Cor, 
Lincoln, NE, USA).
light and electron microscopy
For light microscopy, formalin-fixed lung and hilar lymph-
node tissue samples were dehydrated and embedded in 
paraffin using the standard technique. Sections of 3 µm 
were stained with H&E. Stained sections were photographed 
and evaluated quantitatively with ImageJ software.39 After 
calibration and validation of the system, objects of interest, 
ie, macrophages with phagocytosed TiO
2
 NPs, were marked 
manually on the digitized light-microscopy image, and the 
software calculated their number, total area, and typical maxi-
mal diameter. For TEM, formalin-fixed, paraffin-embedded 
specimens were reembedded into plastic (Embed 812, Sigma-
Aldrich), and 70 nm-thick sections were cut, stained with 
uranium and lead, and placed on oval slot copper grids. They 
were analyzed using TEM (JEOL 1,400 plus 120 kV).
statistics
From individual data, group means and standard devia-
tion were obtained. Depending on the normality of data 
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distribution, checked by the Kolmogorov–Smirnov test, 
one-way ANOVA, and post hoc Tukey’s test (for body and 
organ weights), general linear model with repeated mea-
sures and post hoc Tukey analysis (for BW-growth rate), 
and nonparametric Kruskal–Wallis ANOVA and post hoc 
Mann–Whitney U test with Holm correction (for chemical 
and biochemical data) were applied. P0.05 was set as the 
limit of significance. The software used was SPSS version 
22.0 (IBM, Armonk, NY, USA). Possible linear correlations 
between data sets were tested by the “linear fit” function of 
MS Excel. This function uses the least-squares method to 
fit a straight line to the measurement data and examines the 
strength of relationship with Fisher’s F test.
Results
characterization of TiO2 nanorods
TEM confirmed that the prepared nanomaterial consisted 
of nanorods in the desired size range. The X-ray-diffraction 
pattern verified a crystal structure characteristic of anatase. 
The size of the synthesized TiO
2
 nanorods was found to be 
largely uniform with a narrow distribution range. This was 
verified by dynamic light scattering and TEM in suspension 
(Figure 1; size-distribution curves and average NP sizes 
presented in Figure S1). The stability and shelf-life of the 
synthesized nanomaterial in dry and suspended states was 
satisfactory, as its properties did not change throughout the 
experimental period (Figure 1).
Uptake and internalization of nanorods in 
a549 cells
NPs were observed on the surface of A549 cells treated 
with the suspension of TiO
2
 nanorods by SEM indicating 
the attachment of NPs to the cell membrane. The chemical 
composition of the samples, determined by electron micros-
copy using the EDS detector, further verified the presence 
of Ti. SEM and TEM images of cells after 24-hour treat-
ment with 0.1 mg/mL revealed that TiO
2
 nanorods were not 
only present on the cell surface but were also internalized, 
since TiO
2
 NPs appeared both attached to the membrane 
(Figure 2C and D) and in the cytoplasm (Figure 3) of 
the A549 cells. Intracellularly, TiO
2
 NPs were localized 
mainly in electron dense endosomes, in membrane coated 
?
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????????????????
??
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????
????
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Figure 1 characterization of TiO2 nanorods in a fresh state and after ~4 months of storage.
Notes: TeM images of the new (A) and aged (B) NP suspension; X-ray diffraction patterns (C); size distribution (D) determined by Dls.
Abbreviations: Dls, dynamic light scattering; NP, nanoparticle; TeM, transmission electron microscopy.
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multilamellar and multivesicle bodies. It is of note that no 
NPs were detected in the nuclei or within the mitochondria 
of A549 cells.
effects on cell survival and metabolism
To evaluate toxicity, A549 cells were treated for 24, 48, or 
72 hours with either TiO
2
 nanorods in various concentrations 
(0–2 mg/mL) or with corresponding concentrations of PAA 
(see Methods section). After treatment, cell viability was 
determined by MTT assay. Exposure to TiO
2
 NPs caused 
dose- and time-dependent viability loss in the A549 cell 
culture. In Figure 4A, cell viability after 48 hours’ exposure is 
presented. PAA itself exhibited some effect on cell viability, 
but TiO
2
 nanorods were significantly more toxic compared 
to the stabilizing agent. Administration of the nanorods for 
48 hours decreased cell viability to a higher degree compared 
to 24-hour treatments, demonstrating the time-dependent 
cytotoxicity of TiO
2
 NPs. At the same time, the presence of 
ROS in the treated A549 culture increased to at least double 
the value of PAA-treated cells detected by DCFDA stain-
ing and subsequent quantification of fluorescence intensity 
(Figure 4B). These results suggested that the reduced cell 
survival might have been due to apoptosis. Nevertheless, 
this was not verified by the annexin V–propidium iodide 
test (data not shown).
general toxicity, effects on the body and 
organ weights of the treated rats
Treatment of rats with the TiO
2
 nanorod suspension at 5 and 
18 mg/kg BW dose (Table 1) had no noteworthy effect on 
total BW gain (Table 2) or its rate (not shown). In contrast, 
BW-related weight of the lungs and kidneys increased in all 
treated groups. Most likely, this showed the effect of both 
the PAA-containing medium and the NPs themselves, but 
the net effect of the NPs in the HD group (HD vs VT) was 
significant (Table 2).
?
? ?
?
??
?????????????????????????????? ????????????????????????????????????? ???????
??????
?
?
? ? ???
??
?? ?? ?? ?? ??
?
?
? ? ? ? ???? ? ? ?
Figure 2 seM images of control (A) and TiO2 nanorod-treated a549 cell (B). The cluster of white particles at the lower left region of the cell appeared to be nano-TiO2, 
which was verified by the density of the red color, corresponding to titanium (C), based on the eDs result (D) from the same region. Nanorods in the region with lower red 
density (C) were probably attached to the plasma membrane, while where red density was maximal, they might have already been internalized.
Abbreviations: eDs, energy-dispersive X-ray spectroscopy; seM, scanning electron microscopy.
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A B
C D
E F
Figure 3 Internalization of TiO2 nanorods by a549 cells.
Notes: TeM of a control cell (A, magnification 1,500×) with intact organelles (B, 10,000×) and a nano-TiO2-treated cell (C, 4,000×), showing internalized NPs in multivesicle 
bodies (D, 12,000×). Images of another treated cell (E, 2,000×) reveal a caveola being formed on the cell surface near a cluster of NPs (F, 20,000×). The white frames in A, 
C, and E show the cutouts seen magnified in B, D, and F.
Abbreviations: NPs, nanoparticles; TeM, transmission electron microscopy.
Presence of TiO2 nanorods in treated rat 
lungs, regional lymph nodes, kidneys, and 
blood samples
Chemical analysis by single-particle inductively coupled 
plasma mass spectrometry revealed significant dose-depen-
dent deposition of Ti in NP-treated rat lungs and much lower 
levels of Ti in the blood and kidneys (Table 3), indicating 
that a moderate amount of the NPs managed to get through 
the alveolar–capillary barrier, most probably in phagosomes 
of macrophages, as NPs within epithelial cells or free in the 
interstitium were not observed. The Ti detected in lung tissue 
was present at least partially in NP form, since H&E-stained 
histological sections of the lungs and lymph nodes showed 
macrophages laden with dark particles (Figure 5); therefore, 
this histopathology analysis, especially that of lymph nodes, 
provided further proof that macrophages might be involved in 
the systemic spreading of the instilled NPs. In the LD and HD 
nano-TiO
2
-treated groups, decreased alveolar and increased 
interstitial area was also observed. Quantification of mac-
rophages in light-microscopy images by means of ImageJ 
(Table 3) revealed a highly significant and dose-dependent 
(HD vs LD) difference in their number and also in their 
size. TEM images, showing NPs and their conglomerates of 
several hundred nm located within multivesicle bodies in the 
macrophages (Figure 6), verified the efficient delivery of the 
NPs by the method of administration used by us.
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effects of TiO2 NPs in lung tissue: 
oxidative stress and cytokine activation
Intracellular (and possibly extracellular) presence of TiO
2
 
NPs in lung tissue of rats treated for 28 days contributed 
to an overproduction of ROS (analogously to the higher 
ROS concentration in the TiO
2
-treated A549 cells vs 1% 
PAA-treated cells; Figure 4B), resulting in the generation 
of considerable oxidative stress. MDA levels (and conse-
quently lipid peroxidation) increased significantly in the 
HD group only, while catalase activity was significantly 
raised in both treated groups vs C and VT (Table 4). Also 
of note is that PAA alone (in group VT) had no effect on 
these oxidative stress parameters, despite the effect on lung 
weight (cf Table 2).
The action of TiO
2
 nanorods on lung-tissue cells induced 
a massive activation of various cytokines as well, especially 
within group HD, since the cytokine profile of the HD-group 
sample demonstrated the expression of several molecules 
not present in the other samples, including LD (Figure 7). 
Several of the cytokines detected, such as IL1α and CINC1, 
are known to be involved in acute inflammation and phago-
cyte recruitment. l-selectin promotes diapedesis of the mac-
rophages, whereas VEGF is indicative of the inflammation 
becoming chronic.
Table 2 Body-weight gain in control and treated rats and relative 
weight of lungs and kidneys
BW gain 
(g) during 
treatment
Relative organ weight  
(g/100 g BW)
Lungs Kidneys
c 150.80±30.51 0.52±0.09 0.77±0.09
VT 167.14±70.22 0.60±0.13 0.70±0.05
lD 146.18±23.36 0.69±0.07 0.80±0.07
hD 140.51±13.45 0.86±0.05**,## 0.92±0.05##
Notes: Means ± sD, n=10. **P0.01 vs c; ##P0.01 vs VT.
Abbreviations: BW, body weight; c, control; hD, high dose (18 mg/kg BW); 
lD, low dose (5 mg/kg BW); VT, vehicle-treated.
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Figure 4 concentration- and treatment time-dependent decrease in viability (A) and increase in free-radical generation (B) in a594 cells upon exposure to TiO2 nanorods 
in culture medium.
Abbreviation: Paa, polyacrylic acid.
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Table 3 Presence of Ti in rat lungs, blood, and kidneys: tissue Ti concentrations and image-analysis data of macrophages observed on 
lung-tissue light microscopy sections
Tissue Ti levels (μg/kg BW) ImageJ results, n=10/group
Lungs, n=10/group Blood, n=8/group Kidneys, n=10/group Area Maximal diameter
c 4.16±4.12 153.34±314.41 0.21±0.33 ND ND
VT 2.26±1.84 205.65±387.07 2.06±0.94 ND ND
lD 207.20±72.85**,## 1,077.10±1,672.47 4.01±2.19 725.82±116.85***,### 34.90±2.59***,###
hD 610.44±133.03**,## 1,182.69±1,887.36 7.17±6.14** 1,196.57±168.77***,###,°° 43.00±2.88***,###,°
Notes: Means ± sD; **P0.01, ***P0.001 vs c; ##P0.01, ###P0.001 vs VT; °P0.05, °°P0.01 hD vs lD. area: summed area of the marked-up NP-containing 
macrophages indicative of their number. area and diameter given in arbitrary units.
Abbreviations: BW, body weight; c, control; hD, high dose (18 mg/kg BW); lD, low dose (5 mg/kg BW); VT, vehicle-treated.
? ?
? ?
?
Figure 5 h&e-stained sections of lung (A–D) and hilar lymph-node (E) tissue from animals in groups c (A), VT (B), lD (C), and hD (D, E).
Notes: (C, D) Macrophages laden with TiO2 NPs and thickened (edematous) interstitial mass; (E) large mass of NP-laden macrophages in the lymph node. Bar 200 µm.
Abbreviations: c, control; hD, high dose (18 mg/kg body weight); lD, low dose (5 mg/kg body weight); NP, nanoparticle; VT, vehicle-treated.
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Discussion
Application of the synthesized TiO
2
 nanorods in vitro and 
in vivo by intratracheal instillation resulted in detectable 
internal exposure. Not only was their uptake verified both 
chemically (Figure 2, Table 3) and by electron microscopy 
(phagocytosed NPs and conglomerates in alveolar mac-
rophages, seen in Figure 6D), but moderate effects of cell 
and tissue damage were evoked following in vitro and in vivo 
administrations, respectively.
In our in vivo experiment, no clinical signs of toxicity 
and no mortality were observed in rats treated with 5 and 
18 mg/kg BW TiO
2
 NPs. The BW of control and treated 
rats increased continuously with age, and there were no 
significant differences in this respect at the end of the treat-
ment. The highest Ti level and relative organ weight of 
lungs and kidneys in the HD group vs C group (Tables 2 
and 3) indicated local accumulation of TiO
2
 nanorods and 
NP-related inflammation after the application of 18 mg/kg 
BW TiO
2
 NPs for 28 days. The low dose (5 mg/kg BW), 
however, had no significant effect on Ti levels or relative 
? ?
? ?
? ?
Figure 6 TeM of lung-tissue macrophages from groups c (A), VT (B), lD (C, D), and hD (E, F).
Notes: Magnification: left, 3,000×; right, 12,000×. (D, F) Nanorods within multivesicle bodies can be recognized.
Abbreviations: c, control; hD, high dose (18 mg/kg body weight); lD, low dose (5 mg/kg body weight); TeM, transmission electron microscopy; VT, vehicle-treated.
Table 4 Oxidative stress indicators in control and treated rat 
lung tissue
TBARS
(μM MDA/mg protein)
Catalase activity
(BU/mg protein)
c 1.0389±0.3149 0.00238±0.00034
VT 1.0783±0.3325 0.00214±0.00049
lD 1.0250±0.3855 0.00334±0.00078**,##
hD 1.2985±0.3890* 0.00345±0.00105**,##
Notes: Means ± sD; n=10. *P0.05; **P0.01 vs c; ##P0.01 vs VT.
Abbreviations: BU, Bergmeyer units; c, control; hD, high dose (18 mg/kg body 
weight); lD, low dose (5 mg/kg body weight); MDa, malondialdehyde; TBars, 
thiobarbituric acid-reactive substance; VT, vehicle-treated.
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Figure 7 cytokines detected in lysates of rat lung-tissue samples.
Note: Obtained from animals of groups c (A), VT (B), lD (C), and hD (D) using the rat lung-cytokine array panel.
Abbreviations: c, control; hD, high dose (18 mg/kg body weight); lD, low dose (5 mg/kg body weight); VT, vehicle-treated.
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organ weights. All the same, moderate histopathological 
findings (eg, macrophage proliferation, hyperplasia of the 
alveolar epithelium or the interstitium; Figure 5, Table 3) 
were seen in the alveolar region in LD rat lungs. This sug-
gested a dose-dependent pulmonary inflammatory response 
to the intratracheally administered 15×65 nm TiO
2
 nanorods, 
which was in line with the results of Oyabu et al, who found 
that NP-induced pulmonary inflammation (its type, extent, 
and reversibility) depended on the extent of deposition and 
clearance of NPs in the lung.19
Oxidative stress was verified in both test systems. This is 
not surprising for metal or metal oxide NPs and has also been 
documented for TiO
2
 NPs.40,41 In the latter study, performed 
on A549 cells (the strain used also in our work), spherical 
NPs of various diameters and one elongated, 9×68 nm rod-
shaped NP type were examined; however, the rod and one of 
the spheres had rutile crystal form, whereas the others were 
anatase. The relationship of size, shape, and crystal form to 
cytotoxicity and ROS generation was not straightforward, 
eg, the rutile rods had larger specific surface area, but mostly 
weaker effect than the rutile spheres of 21 nm diameter.41 
Such a relationship, as a possible means of predicting inha-
lation risk of nano-TiO
2
 products, has been tested in rats by 
single intratracheal exposure,29 but the outcome was that 
particle size, but not shape or crystal form, was significantly 
correlated with indicators of acute pulmonary inflammation. 
The findings of Liu et al were partly similar, showing that 
smaller NPs cause dose-dependently more lung damage, but 
in that study the crystal form was not unitary.42 It seems that 
on the basis of presently available literature, the question 
of the relationship between physicochemical features (eg, 
shape) and biological effect of TiO
2
 NPs cannot be definitely 
answered, as was also been concluded in another study.43
In the present work, the crystal form of the TiO
2
 nanorods 
applied in vitro and in vivo was anatase, which is known to 
be a chemically more active form than rutile, inducing more 
severe oxidative stress in biological systems.21 The increase 
in indicators of oxidative stress – elevation of ROS in vitro 
and of TBARS in vivo (Figure 4, Table 4) – was in line with 
that, but in contrast to Wadhwa et al, who reported a lack 
of cytotoxicity of TiO
2
 nanorods on A549 cells.44 However, 
the nanorods in that study were typically longer than those 
used by us, and they have been applied in PBS without addi-
tives, resulting in aggregation. The actual state of the NPs 
in the treatment solution, stably suspended in our work due 
to the addition of PAA (Figure 1), in contrast to aggrega-
tion in the mentioned work, may explain the difference in 
cytotoxicity.
SEM and TEM of TiO
2
 nanorod-treated A549 cells 
(Figures 2C, 3, and 6) displayed NPs in both extra- and 
intracellular positions, including nanorods in multivesicle 
bodies, verifying internalization of the NPs. The multivesicle 
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bodies, membrane-coated cellular organelles containing large 
amounts of nanorods, potentially indicate the involvement of 
autophagy-related mechanisms in TiO
2
 NP-induced toxicity 
both in vitro and in vivo.
Park et al compared the toxicity of TiO
2
 nanorods of 
anatase and brookite crystal form in various cell lines, includ-
ing the human bronchial epithelial cell line BEAS2B and in 
mice.45 In spite of the smaller specific surface area, brookite 
nanorods caused more cytotoxicity and oxidative stress 
in vitro and inflammation of the airways in vivo than anatase, 
and the authors explained this result by the increased presence 
of autophagosomes. This is in parallel with our findings in 
the A549 cell line of alveolar origin (Figure 4).
Autophagy, itself a normal cell-physiology phenom-
enon, seems to be the ultimate way that NPs induce cell 
death.11 Autophagosomes are formed around cell “garbage” 
of internal or external origin, where externals may include 
endocytosed NPs that are attacked by phagocytes of the 
immune system similarly to pathogens.46 The autophago-
somes then fuse with lysosomes to degrade their contents. 
In our nanorod-exposed cells, this process (autophagosomal 
flux) might have been disturbed, resulting in the accumulation 
of unprocessed autophagosomes, as was seen in the TEM of 
TiO
2
 nanorod treated cells.
Consequences of oxidative stress were observed in the 
present work, both in vitro (ROS levels in Figure 4) and 
in vivo (TBARS and catalase-activity levels in Table 4). 
This is in line with Boland et al, reporting multiple species of 
ROS and lipid peroxidation in nano-TiO
2
-treated cells, which 
then lead to damaged lysosomes.47 Lysosomal damage due 
to increased membrane permeability is potentially enhanced 
by larger TiO
2
 NP aggregates.9 These can physically break 
the lysosomal membrane; nevertheless, the overload by 
indigestible particles alone impedes normal lysosomal flow, 
ie, fusion with phagosomes.48 This way, the normal removal 
of defected cell constituents is disturbed, resulting in further 
damage to lysosomes and other organelles, including mito-
chondria. Beyond that, oxidative damage to membrane lipids 
may make the penetration of foreign objects, such as NPs 
and their conglomerates, through the plasma membrane more 
likely, which in turn may lead to the weakening of endo- and 
epithelial barriers.
Such enzymes as cathepsin B released from leaky lyso-
somes would trigger inflammasomes, which in turn activate 
interleukins.47 The spectrum of interleukin activation seen in 
the lung tissue of HD rats (Figure 7) indicated that acute 
inflammation developed in the lungs, which turned chronic 
during the 28-day treatment period. TiO
2
 NPs seem to be 
especially potent in this aspect, inducing the release of both 
IL1α and IL1β.49 IL1α – together with IL1RA – was indeed 
detected in lung tissue of our HD TiO
2
 nanorod-treated ani-
mals. Increased IL1 has also been detected in mice treated 
with anatase and brookite nanorods.45
Part of the acute inflammatory reaction50 and probably 
induced by the mentioned cytokines, CINC1 is also known 
to be involved in pulmonary inflammation, as reported by 
Morimoto et al in a study in which rats were instilled with 
TiO
2
 NPs (rutile).51 The anatase nanorods used in our work 
are generally believed to be more inflammogenic than 
rutile,21 so the induction of LIX and increased production 
of CCL5 in the HD rats was plausible. LIX has also been 
among the chemokines found in the lungs of mice receiv-
ing various metal oxide NPs via the airway.52 Beyond its 
contributing role in inflammation, IL1 is also known to 
promote autophagy, providing further support to the idea 
that the cell death seen in our in vitro work was indeed due 
to autophagy.12
The presence of numerous macrophages containing TiO
2
-
nanorod-laden phagosomes in the lung sections of treated rats 
(Figures 5 and 6) supported the action of the biochemically 
detected chemokines. Infiltration of leukocytes into the pul-
monary parenchyma and alveolar space by transendothelial 
migration, as well as increasing interstitial and decreasing 
alveolar area (Figure 5C and D), was an indication of chronic 
inflammation and required the coordinated action of several 
adhesion molecules. The enhanced presence of l-selectin, a 
surface molecule on leukocytes required for interaction with 
the endothelium of blood vessels,53 in the lung tissue of TiO
2
 
NP-exposed animals (Figure 7) was also in line with that 
hypothesis. The increased production of the proangiogenic 
VEGF, also detected in the HD group (Figure 7) indicated 
that together with l-selectin, local inflammation possibly 
developed into acute systemic inflammation. The angiogenic 
action of VEGF and LIX might further promote fibrotic 
degeneration in the lungs, eventually leading to vanishing 
of the gas-exchange surface, ie, a COPD-like state. Chronic 
consequences found in animals due to TiO
2
 NP exposure 
include not only pulmonary inflammation, leading to, eg, 
an asthma-like state,54 but also myocarditis55 and endothelial 
damage.56 Another consequence of the NP exposure in our 
study, increased lipid peroxidation (Table 4), has also been 
implicated in the pathogenesis of oxidative stress-related 
chronic diseases in the respiratory system (asthma, cystic 
fibrosis, or interstitial lung disease),57 and elsewhere in 
the body (atherosclerosis, other cardiovascular diseases, 
alterations in the digestive tract).58 Fibroblasts are the most 
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essential cell type in the pulmonary interstitium for develop-
ment and shaping of the alveoli. ROS-dependent impairment 
(nucleic acid oxidation) in fibroblasts may play a role in the 
pathogenesis of emphysema.59
Elevated Ti levels in blood samples of the treated rats 
(Table 3) and the presence of nanorod-laden macrophages 
in the hilar lymph nodes (Figure 5E) may indicate that 
the alveolar and capillary barrier could not keep TiO
2
 
NPs from causing systemic exposure. This suggests that 
besides triggering the mentioned inflammogenic effector 
molecules, nanorods could possibly contribute to damage 
in distant organs, as in the case of heart damage in nano-
TiO
2
-exposed mice.60 How and to what extent NPs can 
reach distant organs from the lungs and/or cause a systemic 
exposure are crucial questions. The passage of TiO
2
 NPs 
from the alveoli into the interstitium could be promoted 
by smaller particles and higher concentrations.61 Choi et al 
found that nanospheres of various chemical compositions 
with 34 nm diameter but not larger penetrated from the 
alveolar lumen to other pulmonary compartments, includ-
ing the connective tissues (such as lymph nodes) or the 
capillary lumen 1–24 hours after exposure.62 Very small 
spheres (6 nm) appeared quickly in the kidneys (where 
they showed slow accumulation), and they were excreted 
into the urine at 30 minutes postadministration. This size-
dependent motility is of high importance, and it supports 
our findings of increased blood and kidney Ti levels at 
massive NP deposition in the lungs (Table 3), because (at 
least in one dimension) the nanorods used by us were in 
the 34 nm size range.
Together with the animal experimental data referred to 
and some reports on human health risk (such as COPD-like 
symptoms of nano-TiO
2
-exposed workers),16 our results 
indicate that whether rod-shaped or spherical, nanoparticu-
late TiO
2
 cannot generally be regarded as harmless. In this 
respect, it is of interest what the two applied doses of TiO
2
 
nanorods, 5 and 18 mg/kg BW, would mean in terms of 
human exposure. Based on the daily ventilation volume of 
rats,63 these doses are nominally equal to the atmospheric 
concentrations of 25 and 90 mg/m3 – around two orders of 
magnitude higher than the limits of the National Institute for 
Occupational Safety and Health13 – but the 28-day duration 
of exposure is merely 1/30 of the expectable life span of 
rats, shorter than a typical job career within the human life 
span. On the other hand, 5 and 18 mg/kg BW as instilled 
experimental doses are not excessive, as judged on the basis 
of Shakeel et al.30
Conclusion
Intratracheal instillation of 15×65 nm TiO
2
 nanorods for 
28 days to young healthy rats resulted in oxidative stress and 
subchronic-like inflammation with incipient fibrotic altera-
tions (thickened interstitium). This suggests that humans, 
especially with chronic states of the respiratory system 
like COPD and asthma, might be at higher risk of exposure 
to airborne nano-TiO
2
 than has generally been supposed. 
Translocation of the nanorods to regional lymph nodes and 
kidneys in the HD group further indicated the risk of dam-
age at systemic level or in distant organs. The occupational 
health risk suggested by the results calls for improved safety 
measures. Ideally, limit values and safety measures should 
be specific to the type of NP present. This, however, would 
require knowledge that is not available at the moment, which 
underlines the importance of further studies of the kind pre-
sented in this paper.
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Figure S1 size-distribution curves of TiO2 nanorods in suspension, in fresh state (A), and after 4 months of storage (B).
Note: Equations used to fit the distribution curves and the corresponding coefficient of determination are given in inserts.
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